Scientists around the world are constantly looking for new methods to keep up and respond to a rapidly changing novel SARS-CoV-2 virus. Vaccines have been a huge success, but their global roll out has been slow and not equitable.
To combat this, CanSino Biologics in China have developed an inhaled version of their COVID-19 vaccine, which has had early success in clinical trials. Two inhaled doses of the vaccine, given 28 days apart, produced a similar level of protection, measured by neutralising antibodies, to those of a single injection.
It's hoped that this technology will overcome some of the logistical challenges of a global vaccine rollout, getting more people protected, more rapidly.
Watch the full episode: https://youtu.be/E69zhhvAj0Q
Razor is also on #TikTok: https://vm.tiktok.com/ZMdemYnRU/
From landing on the far side of the moon and building Mars probes to setting up science experiments on the newest space station, it's undeniable that China is already a major player in this era of space exploration. Emma Keeling talks to a range of experts to find out more. 🌕 🪐 🚀
Watch #RAZOR o...
There are at least 1,000 different kinds of plant viruses that exist in nature. They can wipe out large areas of farmland and pose a huge threat to agriculture. Yang Zhao has met the scientists in Beijing who are using the natural defence mechanisms of plants as a means of virus control.
Read m...
Since the 1950s, the mass production of plastic has led to billions of tons of waste every year. Almost a third of all plastic ends up in natural environments, where it remains for hundreds of years. Razor meets the team behind Polymateria, a start up that's hoping to tackle this very urgent prob...
